Abstract
The neurofibromatosis 2 gene (NF2) has recently been isolated and predicted to encode a novel protein related to the moesin–ezrin–radixin family of cytoskeleton–associated proteins. Here we describe a novel isoform of the NF2 transcript that shows differential tissue expression and encodes a modified C terminus of the predicted protein. Mutations affecting both isoforms of the NF2 transcript were detected in multiple tumour types including melanoma and breast carcinoma. These findings provide evidence that alterations in the NF2 transcript occur not only in the hereditary brain neoplasms typically associated with NF2, but also as somatic mutations in their sporadic counterparts and in seemingly unrelated tumour types. The NF2 gene may thus constitute a tumour suppressor gene of more general importance in tumorigenesis.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Rent or buy this article
Prices vary by article type
from$1.95
to$39.95
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Martuza, R.L. & Eldridge, R. Neurofibromatosis 2 (bilateral acoustic neurofibromatosis). New Engl. J. Med. 318, 684–688 (1988).
Kaiser-Kupfer, M.I. et al. The association of posterior capsular lens opacities with bilateral acoustic neuromas In patients with neurofibromatosis type 2. Arch. Ophthalmol. 107, 541–544 (1989).
Eldridge, R., Parry, D.M. & Kaiser-Kupfer, M.I. Neurofibromatosis 2: Clinical heterogeneity and natural history in 39 individuals in 9 families and 16 sporadic cases. Am. J. hum. Genet. 49, 133 (A676) (1991).
Seizinger, B.R., Martuza, R.L. & Gusella, J.F. Loss of genes on chromosome 22 in tumorigenesis of human acoustic neuroma. Nature 322, 644–647 (1986).
Seizinger, B.R. et al. Common pathogenetic mechanism for three tumor types in bilateral acoustic neurofibromatosis. Science 236, 317–319 (1987).
Rouleau, G.A. et al. Genetic linkage of bilateral acoustic neurofibromatosis to a DNA marker on chromosome 22. Nature 329, 246–248 (1987).
Seizinger, B.R., de la Monte, S., Atkins, L., Gusella, J.F. & Martuza, R.L. Molecular genetic approach to human meningioma: loss of genes on chromosome 22. Proc. natn. Acad. Sci U.S.A. 84, 5419–5423 (1987).
Werteleckl, W. et al. Neurofibromatosis 2: clinical and DNA linkage studies of a large kindred. New Engl. J. Med. 319, 278–283 (1988).
Rouleau, G.A. et al. Flanking markers bracket the neurofibromatosis type 2 (NF2) gene on chromosome 22. Am. J. hum. Genet. 46, 323–328 (1990).
Fontaine, B. et al. Parental origin of chromosome 22 loss in sporadic and NF2 neuromas. Genomics 10, 280–283 (1991).
Wolff, R.K. et al. Analysis of chromosome 22 deletions in neurofibromatosis type 2-related tumors. Am. J. hum. Genet. 51, 478–485 (1992).
Trofatter, J.A. et al. A novel moesin-, ezrin -, radixin-like gene is a candidate for the neurofibromatosis 2 tumor suppressor. Cell 72, 791–800 (1993).
Rouleau, G.A. et al. Alteration in a new gene encoding a putative membrane-organizing protein causes neuro-fibromatosis type 2. Nature 363, 515–521 (1993).
Luna, E.J. & Hitt, A.L. Cytoskeleton-plasma membrane interactions. Science 258, 955–964 (1992).
Seizinger, B.R. et al. Report of the committee on chromosome and gene loss in human neoplasia. Cytogenet. cell Genet. 58, 1080–1096 (1991).
Kyte, J. & Doolittle, R.F. A simple method for displaying the hydropathic character of a protein. J. molec. Biol. 157, 105–132 (1982).
Knudson, A.G. Mutation and cancer: a statistical study. Proc. natn. Acad. Sci. U.S.A. 68, 820–823 (1971).
Rubinstein, L.J. Tumours of the central nervous system. Atlas of Tumor Pathology (ed. H.I. Firminger) (Armed Forces Institute of Pathology, Washington, D.C., 1972).
Larsson, C., Byström, C., Skoog, L., Rotstein, S. & Nordenskjöid, M. Genomic alterations in human breast carcinomas. Genes. Chrom. & Cancer 2, 191–197 (1990).
Sato, T. et al. Allelotype of breast cancer: cumulative allele losses promote tumor progression in primary breast cancer. Cancer Res. 50, 7184–7189 (1990).
Chen, L.C. et al. Heterogeneity for allelic loss in human breast cancer. J. natn. Cancer Inst. 84, 506–510 (1992).
Tanaka, N. et al. Loss of heterozygosity on the long arm of chromosome 22 in pheochromocytoma. Genes Chrom. & Cancer 5, 399–403 (1992).
Jenkins, R.B. et al. A cytogenetic study of 53 human gliomas. Cancer Genet. Cytogenet. 39, 253–279 (1989).
Okamoto, M. et al. Loss of constitutional heterozygosity in colon carcinoma from patients with familial polyposis coli. Nature 331, 273–277 (1988).
Miyaki, M. et al. Genetic changes and histopathological types in colorectal tumors from patients with familial adenomatous polyposis. Cancer Res. 50, 7166–7173 (1990).
Yokota, J. et al. Altered expression of the retinoblastoma (RB) gene in small-cell carcinoma of the lung. Oncogene 3, 471–475 (1988).
Malkin, D. et al. Germ line p53 mutations in a familial syndrome of breast cancer, sarcomas, and other neoplasms. Science 250, 1233–1238 (1990).
The, I. et al. Neurofibromatosis type 1 gene mutations in neuroblastoma. Nature Genet. 3, 62–66 (1993).
Andersen, L.B. et al. Mutations in the neurofibromatosis 1 gene in sporadic malignant melanoma cell lines. Nature Genet. 3, 118–121 (1993).
Haber, D.A. & Housman, D.E. Rate-limiting steps: the genetics of pediatric cancers. Cell 64, 5–8 (1991).
Smith, C.W.J., Patton, J.G. & Nadal-Ginard, B. Alternative splicing in the control of gene expression. A. Rev. Genet. 23, 527–577 (1989).
Discher, D., Parra, M., Conboy, J.G. & Mohandas, N. Mechanochemistry of the alternatively spliced spectrin-actin binding domain in membrane skeletal protein 4.1. J. biol. Chem. 268 (10), 7186–7195 (1993).
Chomczynski, P. & Sacchi, N. Single-step method of RNA Isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal. Biochem. 162, 156–158.
Sanger, F., Nicklen, S. & Coulson, A.R. DNA sequencing with chain-termination inhibitors. Proc. natn. Acad. Sci. U.S.A. 74, 5463–5467 (1977).
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Bianchi, A., Hara, T., Ramesh, V. et al. Mutations in transcript isoforms of the neurofibromatosis 2 gene in multiple human tumour types. Nat Genet 6, 185–192 (1994). https://doi.org/10.1038/ng0294-185
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1038/ng0294-185
This article is cited by
-
Cerebrospinal Fluid Hyaluronan and Neurofibromatosis Type 2
Cancer Microenvironment (2018)
-
Role of Merlin/NF2 inactivation in tumor biology
Oncogene (2016)
-
BAP1 mutations in mesothelioma: advances and controversies
Current Pulmonology Reports (2016)
-
Angiomotin binding-induced activation of Merlin/NF2 in the Hippo pathway
Cell Research (2015)
-
Oncogenic role of Merlin/NF2 in glioblastoma
Oncogene (2015)